Andere Sprachen Johnson & Johnson Santiago S.E.

Aktien

JNJ

US4781601046

JNJ

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:24:48 31.05.2024			% 5 Tage	% 1. Jan.
146,9 ^USD	-0,90 %		0,00 %	-6,76 %

20:05	Sektor-Update: Aktien des Gesundheitswesens legen am Freitagnachmittag zu	MT
19:30	Top Midday Stories: SQM, Codelco wollen Lithium abbauen; Moderna erhält Zulassung für RSV-Impfstoff; Tesla ruft über 100.000 Autos zurück; Icahn erwirbt Beteiligung an Caesars	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sector Update: Health Care Stocks Advance Friday Afternoon	20:05
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	19:30
Johnson & Johnson Closes Acquisition of Shockwave Medical	15:33
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	31.05.2024
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30.05.
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	29.05.
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	29.05.
J&J's treatment for depression succeeds in late stage study	29.05.
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	29.05.
Sector Update: Health Care Stocks Fall Late Afternoon	28.05.
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28.05.
Sector Update: Health Care	28.05.
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	28.05.
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	28.05.
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	28.05.
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28.05.
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28.05.
J&J acquires rights to skin disorder drug for $1.25 bln	28.05.
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	22.05.
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	22.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

Die Medikamentenpipeline ist für 2024 gut positioniert, sagt J&J CFO

Am 23. Januar 2024 um 18:30 Uhr